Clinical Trial Update: Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sorafenib in combination with infusional 5-fluorouracil for advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Italian Trial in Medical Oncology | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED